Wound drug 'could speed healing'
Wound drug ‘could speed healing’
Early tests of the drug suggests it may more than halve the healing time in some cases.
Wound drug ‘could speed healing’
Early tests of the drug suggests it may more than halve the healing time in some cases.
Genentech Will Ride Out Drug Failure
Even Genentech gets bad news once in a while. But the failure of clinical trials of Tarceva, a pill being developed with tiny OSI Pharmaceuticals of Melville, N.Y, as a first-line treatment in non-small cell lung cancer was widely expected. The real test of the drug will come from other clinical trials already being conducted.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Recent Comments